Yea Christopher 4
4 · KalVista Pharmaceuticals, Inc. · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-20$0.00/sh+87,390$376→ 220,964 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-11-20−87,390→ 0 totalExercise: $0.00Exp: 2026-03-30→ Common Stock (87,390 underlying)
Footnotes (1)
- [F1]This option is 100% vested and exercised.